Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lorenzo Brunetti

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Cancer Discovery|July 24, 2021
Actinomycin D Targets NPM1c-Primed Mitochondria to Restore PML-Driven Senescence in AML TherapyHsin-Chieh Wu, Domitille Rérolle, Caroline Berthier, et al.
Blood Advances|July 28, 2020
Large-scale GMP-compliant CRISPR-Cas9-mediated deletion of the glucocorticoid receptor in multivirus-specific T cellsRafet Basar, May Daher, Nadima Uprety, et al.
Blood Advances|February 24, 2026
Impact of fitness categorization according to SIE/SIES/GITMO criteria in therapy-related and AML-MRC receiving CPX-351Raffaele Palmieri, Fabio Guolo, Luana Fianchi, et al.
Blood Advances|December 5, 2025
Impact of fitness categorization according to SIE/SIES/GITMO criteria in therapy-related and AML-MRC receiving CPX-351Raffaele Palmieri, Fabio Guolo, Luana Fianchi, et al.
Blood Cancer Journal|October 27, 2025
Real-world multicenter analysis of CPX-351 efficacy in patients aged less than 60 years with secondary acute myeloid leukemiaCalogero Vetro, Bruno Garibaldi, Francesco Grimaldi, et al.
American Journal of Hematology|September 24, 2025
Real World Study on the Best CPX-351 Treatment Duration and Timing for Allogeneic Stem Cell TransplantationFabio Guolo, Luana Fianchi, Maria Paola Martelli, et al.
Blood Cancer Journal|December 4, 2025
Correction: Real-world multicenter analysis of CPX-351 efficacy in patients aged less than 60 years with secondary acute myeloid leukemiaCalogero Vetro, Bruno Garibaldi, Francesco Grimaldi, et al.
Blood|September 9, 2020
Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cellsMay Daher, Rafet Basar, Elif Gokdemir, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Cancer Discovery|July 24, 2021
Actinomycin D Targets NPM1c-Primed Mitochondria to Restore PML-Driven Senescence in AML TherapyHsin-Chieh Wu, Domitille Rérolle, Caroline Berthier, et al.
Blood Advances|July 28, 2020
Large-scale GMP-compliant CRISPR-Cas9-mediated deletion of the glucocorticoid receptor in multivirus-specific T cellsRafet Basar, May Daher, Nadima Uprety, et al.
Blood Advances|February 24, 2026
Impact of fitness categorization according to SIE/SIES/GITMO criteria in therapy-related and AML-MRC receiving CPX-351Raffaele Palmieri, Fabio Guolo, Luana Fianchi, et al.
Blood Advances|December 5, 2025
Impact of fitness categorization according to SIE/SIES/GITMO criteria in therapy-related and AML-MRC receiving CPX-351Raffaele Palmieri, Fabio Guolo, Luana Fianchi, et al.
Blood Cancer Journal|October 27, 2025
Real-world multicenter analysis of CPX-351 efficacy in patients aged less than 60 years with secondary acute myeloid leukemiaCalogero Vetro, Bruno Garibaldi, Francesco Grimaldi, et al.
American Journal of Hematology|September 24, 2025
Real World Study on the Best CPX-351 Treatment Duration and Timing for Allogeneic Stem Cell TransplantationFabio Guolo, Luana Fianchi, Maria Paola Martelli, et al.
Blood Cancer Journal|December 4, 2025
Correction: Real-world multicenter analysis of CPX-351 efficacy in patients aged less than 60 years with secondary acute myeloid leukemiaCalogero Vetro, Bruno Garibaldi, Francesco Grimaldi, et al.
Blood|September 9, 2020
Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cellsMay Daher, Rafet Basar, Elif Gokdemir, et al.
Pageof 6